Browse > Article
http://dx.doi.org/10.15324/kjcls.2020.52.4.327

Relationship between Metabolic Syndrome, Metabolic Syndrome Score, Insulin Resistance and Beta Cell Function in Korean Adults with Obesity  

Yoon, Hyun (Department of Clinical Laboratory Science, Wonkwang Health Science University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.52, no.4, 2020 , pp. 327-334 More about this Journal
Abstract
The present study was conducted to assess the relationship between metabolic syndrome, metabolic syndrome score, homeostasis model assessment of insulin resistance (HOMA-IR), and beta-cell function (HOMA-B) in obese Korean adults. The study included 1,860 adults aged 20 years or older from the 2010 Korean National Health and Nutrition Examination Survey (KNHANES) data. Metabolic syndrome and metabolic syndrome score (MSS) were positively associated with HOMA-IR (both P<0.001). HOMA-B levels of elevated blood pressure (P<0.001) and elevated fasting blood glucose group (P<0.001) were significantly lower than the normal group. However, the HOMA-B levels of abdominal obesity (P=0.003) and reduced high-density lipoprotein cholesterol group (P=0.030) were significantly higher than the normal group. Nevertheless, metabolic syndrome (P<0.001) and MSS (P<0.001) were inversely associated with the HOMA-B levels. In conclusion, metabolic syndrome and MSS were positively associated with insulin resistance and inversely associated with beta-cell function in Korean adults with obesity.
Keywords
Beta cell function; Insulin resistance; Metabolic syndrome; Metabolic syndrome score; Obesity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. https://doi.org/10.1007/BF00280883   DOI
2 Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27:2813-2818. https://doi.org/10.2337/diacare.27.12.2813   DOI
3 Misra A, Chowbey PK, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163-170. PMID: 19582986
4 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497. https://doi.org/10.1001/jama.285.19.2486   DOI
5 WHO Western Pacific Region; International Association for the Study of Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000. p15-21.
6 Yoon H, Kim GS, Kim SG, Moon AE. The relationship between metabolic syndrome and increase of metabolic syndrome score and serum vitamin D levels in Korean adults: 2012 Korean National Health and Nutrition Examination Survey. J Clin Biochem Nutr. 2015;57:82-87. https://doi.org/10.3164/jcbn.15-31   DOI
7 Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609-1616. https://doi.org/10.1001/archinte.168.15.1609   DOI
8 James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9:228-233. https://doi.org/10.1038/oby.2001.123   DOI
9 Kaidar-Person O, Bar-Sela G, Person B. The two major epidemics of the twenty-first century: obesity and cancer. Obes Surg. 2011;21:1792-1797. https://doi.org/10.1007/s11695-011-0490-2   DOI
10 Yin J, Li M, Xu L, Wang Y, Cheng H, Zhao X, et al. Insulin resistance determined by homeostasis model assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013;5:71. https://doi.org/10.1186/1758-5996-5-71   DOI
11 Ying X, Song Zh, Zhao Ch, Jiang Y. Association between homeostasis model assessment of insulin resistance (HOMA-IR) and components of metabolic syndrome in young Chinese men. Iran J Public Health, 2011;40:1-5. PMID: 23113066
12 Yamada C, Moriyama K, Takahashi E. Association between insulin resistance and metabolic syndrome risk factors in Japanese. J Diabetes Investig. 2012;28:185-190. https://doi.org/10.1111/j.2040-1124.2011.00162.x   DOI
13 Gobato AO, Vasques AC, Zambon MP, Barros Filho Ade A, Hessel G. Metabolic syndrome and insulin resistance in obese adolescents. Rev Paul Pediatr. 2014;32:55-62. https://doi.org/10.1590/s0103-05822014000100010   DOI
14 Margoth C, Carlos GT, Susana R, Marcos M. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity. BMC Pediatr. 2008;8:31. https://doi.org/10.1186/1471-2431-8-31   DOI
15 Imamura F, Mukamal KJ, Meigs JB, Luchsinger JA, Ix JH, Siscovick DS, et al. Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the cardiovascular health study. Am J Epidemiol. 2013;177:1418-1429. https://doi.org/10.1093/aje/kws440   DOI
16 Howard BV, Mayer-Davis EJ, Goff D, Zaccaro DJ, Laws A, Robbins DC, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism. 1998;47:1174-1179. https://doi.org/10.1016/s0026-0495(98)90319-5   DOI
17 Spence-Jones G. Overview of obesity. Crit Care Nurs Q. 2003;26:83-88. https://doi.org/10.1097/00002727-200304000-00002   DOI
18 Reaven GM. Role of insulin resistance in human disease. Diabetes. 1998;37:1598-1607. https://doi.org/10.2337/diab.37.12.1595   DOI
19 Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB Jr D, Haffner SM, Sholinsky P, et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study. Diabetes. 1996;45:1547-1555. https://doi.org/10.2337/diab.45.11.1547   DOI
20 Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, et al. Obesity, body fat distribution, insulin sensitivity and islet beta-cell function as explanations for metabolic diversity. J Nutr. 2001;131:354-360. https://doi.org/10.1093/jn/131.2.354S   DOI
21 Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, Frank A, et al. Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects. Diabetes. 2004;53:624-632. https://doi.org/10.2337/diabetes.53.3.624   DOI
22 Garg MK, Dutta MK, Mahalle N. Study of beta-cell function (by HOMA model) in metabolic syndrome. Indian J Endocrinol Metab. 2011;15(Suppl 1):44-49. https://doi.org/10.4103/2230-8210.83059   DOI
23 Kim KA, Lee MS. Role and mechanism of pancreatic β-cell death in diabetes: the emerging role of autophagy. J Diabetes Invest. 2010;1:232-238. https://doi.org/10.1111/j.2040-1124.2010.00054.x   DOI
24 Kasuga M. Insulin resistance and pancreatic beta cell failure. J Clin Invest. 2006;116:1756-1760. https://doi.org/10.1172/JCI29189   DOI
25 Liu YQ, Jetton TL, Leahy JL. Beta cell adaptation to insulin resistance. Increased pyruvate carboxylase and malate-pyruvate shuttle activity in islets of nondiabetic Zucker fatty rats. J Biol Chem. 2002;277:39163-39168. https://di.org/10.1074/jbc.M207157200   DOI
26 Chen C, Hosokawa H, Bumbalo LM, Leahy JL. Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells. J Clin Invest. 1994;94:399-404. https://doi.org/10.1172/JCI117335   DOI
27 Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA. 1998;95:2498-2502. https://doi.org/10.1073/pnas.95.5.2498   DOI
28 Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, et al. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes. 1999;48:2398-2406. https://doi.org/10.2337/diabetes.48.12.2398   DOI
29 Cubeddu LX, Hoffmann IS. Impact of traits of metabolic syndrome on beta-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects. Metabol Synd Relat Disord. 2012;10:344-350. https://doi.org/10.1089/met.2012.0040   DOI
30 Baez-Duarte BG, Sanchez-Guillen MDC, Perez-Fuentes R, Zamora-Ginez I, Leon-Chavez BA, Revilla-Monsalve C, et al. β-cell function is associated with metabolic syndrome in Mexican subjects. Diabetes Metab Syndr Obes. 2010;3:309-311. https://doi.org/10.2147/DMSOTT.S12375   DOI
31 Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101:975-980. https://doi.org/10.1161/01.cir.101.9.975   DOI
32 Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, et al. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: effects of lifestyle intervention and metformin. Diabetes. 2005;54:2404-2414. https://doi.org/10.2337/diabetes.54.8.2404   DOI
33 Hanley AJ, Wagenknecht LE, D'Agostino RB Jr, Zinman B, Haffner SM. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes. 2003;52:2740-2747. https://doi.org/10.2337/diabetes.52.11.2740   DOI
34 Zhou L, Zhang J, Fang Q, Liu M, Liu X, Jia W, et al. Autophagymediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance. Mol Pharmacol. 2009;76:596-603. https://doi.org/10.1124/mol.109.057067   DOI
35 Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, et al. Loss of ARNT/HIF1 beta mediates altered gene expression and pancreatic islet dysfunction in human type 2 diabetes. Cell. 2005;122:337-349. https://doi.org/10.1016/j.cell.2005.05.027   DOI
36 Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations: insulin resistance atherosclerosis study (IRAS) Investigators. Arterioscler Thromb Vasc Biol. 1997;17:64-71. https://doi.org/10.1161/01.atv.17.1.64   DOI
37 Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014;29:405-409. https://doi.org/10.3803/EnM.2014.29.4.405   DOI
38 Robertson RP, Zhou H, Zhang T, Harmon JS. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys. 2007;48:139-146. https://doi.org/10.1007/s12013-007-0026-5   DOI